STVN
Stevanato Group S.p.A.
STVN
Stevanato Group S.p.A.
Stevanato Group NYSE: STVN reported second-quarter 2026 revenue growth of 8% as demand for higher-value drug containment and delivery products helped lift profitability, while the company updated its
Stevanato Group S.p.A. (STVN) Q2 2026 Earnings Call Transcript